Mintz provided legal counsel to HealthpointCapital, a private equity firm focused exclusively on the musculoskeletal sector, in connection with its acquisition of a majority stake in medical device company IlluminOss Medical, Inc. (IlluminOss). The transaction was announced on May 1.
East Providence, Rhode Island-based IlluminOss offers a unique and disruptive technology for the orthopedic trauma market through its Photodynamic Bone Stabilization System, which is a minimally invasive approach for fracture repair through a patient-specific intramedullary implant. The IlluminOss system utilizes a light-curable polymer, contained within an expandable balloon catheter, to achieve bone stabilization.
The system is CE-marked in Europe and U.S. Food and Drug Administration (FDA)-cleared in the United States for the treatment of a variety of traumatic, fragility and pathological fractures. HealthpointCapital will partner with the IlluminOss team to drive rapid growth and expand regulatory approvals for additional anatomical indications. Notably, the IlluminOss technology is covered by over 110 issued patents in the United States and internationally, with additional patent applications pending.
The Mintz team that advised HealthpointCapital was led by Members Stephen Curley and James McKnight and included Members David Lagasse, Avi Reshtick and William Geary, as well as Associates Daniel Bosworth, Alexander Song, Benjamin Zegarelli, David Salamon and Derek Constantine.